| 05/20/2026 3:18 PM | 20/20 Biolabs (1139685) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 04/28/2026 6:57 AM | 20/20 Biolabs (1139685) Filer | Form 424B3 | |
| 04/28/2026 6:59 AM | 20/20 Biolabs (1139685) Filer | Form 424B3 | |
| 04/28/2026 6:43 AM | 20/20 Biolabs (1139685) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 04/13/2026 3:28 PM | 20/20 Biolabs (1139685) Filer | Form 424B3 | |
| 04/13/2026 3:29 PM | 20/20 Biolabs (1139685) Filer | Form 424B3 | |
| 04/12/2026 11:15 PM | 20/20 Biolabs (1139685) Filer | Form EFFECT | |
| 04/09/2026 11:15 PM | 20/20 Biolabs (1139685) Filer | Form EFFECT | |
| 04/06/2026 4:56 PM | 20/20 Biolabs (1139685) Issuer Zhou Jiming (2109760) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 4:56 PM | 20/20 Biolabs (1139685) Issuer Bergman Alan B. (1907908) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 4:28 PM | 20/20 Biolabs (1139685) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
Get the Latest News and Ratings for AIDX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for 20/20 Biolabs and its competitors with MarketBeat's FREE daily newsletter.
|
| 04/06/2026 4:21 PM | 20/20 Biolabs (1139685) Filer | Form POS AM | |
| 03/31/2026 4:26 PM | 20/20 Biolabs (1139685) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 03/10/2026 4:18 PM | 20/20 Biolabs (1139685) Subject Full Succeed International Ltd (2117992) Filed by | Form SCHEDULE 13G | |
| 03/04/2026 4:48 PM | 20/20 Biolabs (1139685) Issuer Cohen Jonathan M (2111543) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/25/2026 2:10 PM | 20/20 Biolabs (1139685) Subject Streeterville Capital LLC (1851416) Filed by | Form SCHEDULE 13G | |
| 02/23/2026 6:09 PM | 20/20 Biolabs (1139685) Issuer Rollins John Woodson (2112941) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 5:12 PM | 20/20 Biolabs (1139685) Issuer Rollins John Woodson (2112941) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/23/2026 5:13 PM | 20/20 Biolabs (1139685) Issuer COHEN RICHARD M (1075891) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 5:13 PM | 20/20 Biolabs (1139685) Issuer Compton John G. (2107487) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/23/2026 5:13 PM | 20/20 Biolabs (1139685) Issuer Ross Michael A. (2109744) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/19/2026 4:52 PM | 20/20 Biolabs (1139685) Issuer Cohen Jonathan M (2111543) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 11:15 PM | 20/20 Biolabs (1139685) Filer | Form EFFECT | |
| 02/17/2026 5:27 PM | 20/20 Biolabs (1139685) Issuer Ross Michael A. (2109744) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:27 PM | 20/20 Biolabs (1139685) Issuer COHEN RICHARD M (1075891) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:28 PM | 20/20 Biolabs (1139685) Issuer Zhou Jiming (2109760) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:28 PM | 20/20 Biolabs (1139685) Issuer Compton John G. (2107487) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:28 PM | 20/20 Biolabs (1139685) Issuer Reddy Prasanth (2109266) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:28 PM | 20/20 Biolabs (1139685) Issuer Bergman Alan B. (1907908) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:29 PM | 20/20 Biolabs (1139685) Issuer Baker Ron (2109536) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/17/2026 5:29 PM | 20/20 Biolabs (1139685) Issuer Lebowitz Michael Saul (2109528) Reporting | Form 3 Initial statement of beneficial ownership of securities | |
| 02/13/2026 2:35 PM | 20/20 Biolabs (1139685) Filer | Form 8-A12B | |
| 01/26/2026 1:51 PM | 20/20 Biolabs (1139685) Filer | Form S-1/A | |
| 01/21/2026 3:50 PM | 20/20 Biolabs (1139685) Filer | Form S-1/A | |
| 12/18/2025 4:24 PM | 20/20 Biolabs (1139685) Filer | Form 1-U Current Report Pursuant to Regulation A | |
| 12/18/2025 4:27 PM | 20/20 Biolabs (1139685) Filer | Form 1-K/A | |
| 12/12/2025 4:19 PM | 20/20 Biolabs (1139685) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 12/12/2025 11:56 AM | 20/20 Biolabs (1139685) Filer | Form C/A | |
| 11/26/2025 1:16 PM | 20/20 Biolabs (1139685) Filer | Form C/A | |
| 11/21/2025 2:16 PM | 20/20 Biolabs (1139685) Filer | Form 1-U Current Report Pursuant to Regulation A | |
| 11/04/2025 8:53 AM | 20/20 Biolabs (1139685) Filer | Form C/A | |
The SpaceX filing is public. The window is closing. (Ad) SpaceX just filed its S-1. The IPO is confirmed for June 12 - $75 billion, ticker SPCX, potentially the largest in history. The 21-bank syndicate has already locked up shares, so retail investors won't get access.
But the S-1 exposed one publicly traded company Musk cannot operate without - and it's still cheap. Dylan Jovine is releasing the ticker free before June 12 changes the price. Get the ticker before the SpaceX IPO reprices everything on June 12 |
| 10/30/2025 1:05 PM | 20/20 Biolabs (1139685) Filer | Form C Form C | |
| 08/13/2025 1:47 PM | 20/20 Biolabs (1139685) Filer | Form C-U | |
| 07/08/2025 2:48 PM | 20/20 Biolabs (1139685) Filer | Form C/A | |
| 07/08/2025 9:27 AM | 20/20 Biolabs (1139685) Filer | Form C/A | |